Nura Bio

South San Francisco, United States

Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.

Jun 2026

Series B

Top Investors

Samsara BioCapitalThe Column GroupSanofi VenturesEuclidean Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Nura Bio's investors?

Nura Bio's investors include Samsara BioCapital, The Column Group, Sanofi Ventures, Euclidean Capital.

Where is Nura Bio headquartered?

Nura Bio is headquartered in South San Francisco, United States.

What does Nura Bio do?

Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.

What stage is Nura Bio at?

Nura Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 22, 2026.

MLA

"Nura Bio — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/nura-bio. Accessed June 30, 2026.

APA

VCBacked. (2026). Nura Bio — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/nura-bio

Wikipedia (cite web)

{{cite web |title=Nura Bio — Funding & Investors |url=https://www.vcbacked.co/company/nura-bio |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 22, 2026.